Piper Sandler Reiterates Overweight Rating on Guardant Health (GH) After a 'Positive' Survey
Tweet Send to a Friend
Piper Sandler analyst David Westenberg reiterated an Overweight rating and $34.00 price target on Guardant Health (NASDAQ: GH).The analyst said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
